Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Precision Drilling
PDS
US OptionsDetailed Quotes
IRON250516C65000
- 0.00
- 0.000.00%
15min DelayClose May 12 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest65.00Strike Price0.00Turnover0.00%IV39.46%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma9.51Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Disc Medicine Newsroom
Disc Medicine Is Maintained at Outperform by BMO Capital
BMO Capital Maintains Outperform on Disc Medicine, Raises Price Target to $120
Disc Medicine Analyst Ratings
Disc Medicine's Promising Position in MF Anemia Treatment: Buy Rating Affirmed by Evan Seigerman
Analysts Are Bullish on These Healthcare Stocks: Disc Medicine (IRON), Trevi Therapeutics (TRVI)
Express News | Disc Medicine Inc : BMO Raises Target Price to $120 From $112
Buy Rating for Disc Medicine Driven by Promising Bitopertin Prospects and Strategic Advancements
Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation
Promising Developments at Disc Medicine: NDA Filing and Phase III Trial for Bitopertin in EPP
LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $85
Disc Medicine's Strong Financial Health and Promising Clinical Pipeline Justify Buy Rating
Disc Medicine | 10-Q: Q1 2025 Earnings Report
Disc Medicine Reports Q1 EPS ($1.02), Consensus ($1.07)
Disc Medicine | 8-K: Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
Disc Medicine Ended 1Q With $695M in Cash, Cash Equivalents, and Marketable Securities, Which Is Expected to Fund Ops Into 2028 >IRON
Disc Medicine 1Q Loss/Shr $1.02 >IRON
Disc Medicine 1Q Loss $34.1M >IRON
Express News | Disc Medicine Q1 Basic EPS USD -1.02 Vs. IBES Estimate USD -1.13
Express News | Disc Medicine Q1 Operating Expenses USD 39.946 Million
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
